Omeros Co. (OMER) Receives Overweight Rating from Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their overweight rating on shares of Omeros Co. (NASDAQ:OMER) in a report issued on Friday. Cantor Fitzgerald currently has a $21.00 price objective on the biopharmaceutical company’s stock.

A number of other equities research analysts have also weighed in on the stock. Maxim Group restated a buy rating and issued a $22.00 target price (up previously from $19.00) on shares of Omeros in a report on Friday. Needham & Company LLC restated a buy rating and issued a $22.00 target price (down previously from $24.00) on shares of Omeros in a report on Friday. Zacks Investment Research upgraded shares of Omeros from a sell rating to a hold rating in a report on Wednesday, March 15th. FBR & Co restated a buy rating on shares of Omeros in a report on Thursday, March 2nd. Finally, Wedbush restated an outperform rating and issued a $47.00 target price on shares of Omeros in a report on Tuesday, February 21st. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The stock has a consensus rating of Buy and an average target price of $33.38.

Omeros (NASDAQ:OMER) traded up 12.90% during trading on Friday, reaching $11.90. The company had a trading volume of 2,387,908 shares. The company has a 50-day moving average price of $11.05 and a 200 day moving average price of $10.51. The company’s market capitalization is $510.69 million. Omeros has a one year low of $7.20 and a one year high of $16.38.

Your IP Address:

A number of large investors have recently modified their holdings of the company. Ingalls & Snyder LLC increased its stake in shares of Omeros by 15.2% in the third quarter. Ingalls & Snyder LLC now owns 5,085,949 shares of the biopharmaceutical company’s stock worth $56,759,000 after buying an additional 671,370 shares during the last quarter. Bank of Montreal Can increased its stake in shares of Omeros by 20.2% in the third quarter. Bank of Montreal Can now owns 2,015,248 shares of the biopharmaceutical company’s stock worth $22,490,000 after buying an additional 338,263 shares during the last quarter. Cpcm LLC purchased a new stake in shares of Omeros during the fourth quarter worth about $12,709,000. Tocqueville Asset Management L.P. increased its stake in shares of Omeros by 0.4% in the third quarter. Tocqueville Asset Management L.P. now owns 959,744 shares of the biopharmaceutical company’s stock worth $10,711,000 after buying an additional 3,741 shares during the last quarter. Finally, State Street Corp increased its stake in shares of Omeros by 4.6% in the fourth quarter. State Street Corp now owns 943,121 shares of the biopharmaceutical company’s stock worth $9,362,000 after buying an additional 41,284 shares during the last quarter. 47.94% of the stock is owned by institutional investors and hedge funds.

About Omeros

Omeros Corporation is a biopharmaceutical company engaged in discovering, developing and commercializing small-molecule and protein therapeutics for market, as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. The Company’s marketed drug product, Omidria (phenylephrine and ketorolac injection), is used during cataract surgery or intraocular lens replacement.

5 Day Chart for NASDAQ:OMER

Receive News & Ratings for Omeros Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omeros Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Nike Suspends Relationship with Maria Sharapova
Nike Suspends Relationship with Maria Sharapova
Rob Bironas Ex-Titans Kicker Dies in Car Crash
Rob Bironas Ex-Titans Kicker Dies in Car Crash
Ron Washington Leaves Texas Rangers Due to an Affair
Ron Washington Leaves Texas Rangers Due to an Affair
Jonathan Dwyer Falls in Line with Other Banned NFL Players
Jonathan Dwyer Falls in Line with Other Banned NFL Players
Tony Stewart Case Going to the Grand Jury
Tony Stewart Case Going to the Grand Jury
Oscar Pistorius “Blade Runner” Found Not Guilty of Murder
Oscar Pistorius “Blade Runner” Found Not Guilty of Murder


Leave a Reply

 
© 2006-2017 Web Breaking News.